BLRX
BioLineRx Ltd.Company with tickers: BLRX
CIK
1498403
CUSIP
09071M304
Shares Outstanding
4,351,357
13F Activity (30d)
11 filings
9 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2022-08-16 | 2022-06-30 | |
| 6-K | 2022-09-12 | — | |
| 6-K | 2022-09-15 | — | |
| 6-K | 2022-09-19 | — | |
| 6-K | 2022-09-21 | — | |
| 6-K | 2022-09-27 | — | |
| 6-K | 2022-11-03 | — | |
| 6-K | 2022-11-04 | — | |
| 6-K | 2022-11-10 | — | |
| 6-K | 2022-11-15 | — | |
| 6-K | 2022-12-20 | — | |
| 6-K | 2023-01-04 | — | |
| 6-K | 2023-03-06 | — | |
| 6-K | 2023-03-22 | — | |
| 20-F | 2023-03-22 | 2022-12-31 | |
| 6-K | 2023-04-17 | — | |
| 6-K | 2023-04-25 | — | |
| 6-K | 2023-05-24 | — | |
| 6-K | 2023-06-23 | — | |
| 6-K | 2023-07-17 | — | |
| 6-K | 2023-08-08 | — | |
| 6-K | 2023-08-30 | — | |
| 6-K | 2023-08-30 | 2023-06-30 | |
| 6-K | 2023-09-11 | — | |
| 6-K | 2023-09-28 | — | |
| 6-K | 2023-10-12 | — | |
| 6-K | 2023-11-20 | — | |
| 6-K | 2023-12-12 | — | |
| 6-K | 2023-12-21 | — | |
| 6-K | 2024-02-16 | — | |
| 6-K | 2024-02-28 | — | |
| 6-K | 2024-03-04 | — | |
| 6-K | 2024-03-26 | — | |
| 20-F | 2024-03-26 | 2023-12-31 | |
| 6-K | 2024-04-01 | — | |
| 6-K | 2024-04-10 | — | |
| 6-K | 2024-04-17 | — | |
| 6-K | 2024-05-06 | — | |
| 6-K | 2024-05-17 | — | |
| 6-K | 2024-05-24 | — | |
| 6-K | 2024-05-28 | — | |
| 6-K | 2024-05-30 | — | |
| 6-K | 2024-06-18 | — | |
| 6-K | 2024-08-15 | 2024-06-30 | |
| 6-K | 2024-08-19 | — | |
| 6-K | 2024-10-01 | — | |
| 6-K | 2024-10-16 | — | |
| 6-K | 2024-11-05 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-21 | — |
Showing 51–100 of 123 filings